Sundrug Co.,Ltd. (TYO:9989)
3,627.00
-59.00 (-1.60%)
May 29, 2026, 3:30 PM JST
Sundrug Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 70,523 | 64,956 | 69,698 | 80,872 | 89,330 |
Cash & Short-Term Investments | 70,523 | 64,956 | 69,698 | 80,872 | 89,330 |
Cash Growth | 8.57% | -6.80% | -13.82% | -9.47% | 3.28% |
Accounts Receivable | 32,330 | 29,994 | 26,740 | 22,219 | 19,104 |
Other Receivables | 19,166 | 18,390 | 15,900 | 15,284 | 14,352 |
Receivables | 51,496 | 48,384 | 42,640 | 37,503 | 33,456 |
Inventory | 110,322 | 98,674 | 91,292 | 83,027 | 72,541 |
Other Current Assets | 5,723 | 4,763 | 4,613 | 4,505 | 4,210 |
Total Current Assets | 238,064 | 216,777 | 208,243 | 205,907 | 199,537 |
Property, Plant & Equipment | 148,487 | 136,706 | 120,536 | 100,248 | 77,855 |
Long-Term Investments | 63,956 | 64,653 | 65,688 | 29,428 | 27,425 |
Goodwill | 1,325 | 1,440 | 1,556 | 1,671 | 2 |
Other Intangible Assets | 6,776 | 7,229 | 7,587 | 7,433 | 5,952 |
Long-Term Deferred Tax Assets | 9,942 | 9,836 | 8,951 | 7,978 | 7,291 |
Other Long-Term Assets | 2 | 2 | 2 | 2 | 2 |
Total Assets | 475,505 | 444,007 | 420,208 | 360,672 | 325,768 |
Accounts Payable | 82,707 | 79,731 | 77,371 | 74,006 | 67,029 |
Short-Term Debt | 1,000 | 1,000 | 35,000 | - | - |
Current Portion of Long-Term Debt | 5,139 | 3,800 | - | - | - |
Current Income Taxes Payable | 8,504 | 8,180 | 7,547 | 8,249 | 5,199 |
Other Current Liabilities | 36,685 | 35,796 | 35,548 | 30,994 | 23,817 |
Total Current Liabilities | 134,035 | 128,507 | 155,466 | 113,249 | 96,045 |
Long-Term Debt | 42,076 | 33,866 | - | - | - |
Pension & Post-Retirement Benefits | 2,504 | 2,383 | 2,473 | 2,296 | 1,696 |
Other Long-Term Liabilities | 10,889 | 9,537 | 9,179 | 8,799 | 7,435 |
Total Liabilities | 189,504 | 174,293 | 167,118 | 124,344 | 105,176 |
Common Stock | 3,931 | 3,931 | 3,931 | 3,931 | 3,931 |
Additional Paid-In Capital | 7,577 | 7,533 | 7,496 | 7,430 | 7,430 |
Retained Earnings | 279,859 | 263,754 | 247,272 | 230,658 | 215,145 |
Treasury Stock | -3,843 | -3,868 | -3,894 | -3,940 | -3,939 |
Comprehensive Income & Other | -1,523 | -1,636 | -1,715 | -1,751 | -1,975 |
Shareholders' Equity | 286,001 | 269,714 | 253,090 | 236,328 | 220,592 |
Total Liabilities & Equity | 475,505 | 444,007 | 420,208 | 360,672 | 325,768 |
Total Debt | 48,215 | 38,666 | 35,000 | - | - |
Net Cash (Debt) | 22,308 | 26,290 | 34,698 | 80,872 | 89,330 |
Net Cash Growth | -15.15% | -24.23% | -57.09% | -9.47% | 3.28% |
Net Cash Per Share | 190.70 | 224.77 | 296.71 | 691.62 | 764.00 |
Filing Date Shares Outstanding | 116.98 | 116.97 | 116.95 | 116.92 | 116.92 |
Total Common Shares Outstanding | 116.98 | 116.97 | 116.95 | 116.92 | 116.92 |
Working Capital | 104,029 | 88,270 | 52,777 | 92,658 | 103,492 |
Book Value Per Share | 2444.81 | 2305.89 | 2164.06 | 2021.22 | 1886.64 |
Tangible Book Value | 277,900 | 261,045 | 243,947 | 227,224 | 214,638 |
Tangible Book Value Per Share | 2375.56 | 2231.78 | 2085.88 | 1943.36 | 1835.71 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.